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Abstract
Background: Long-term care for patients with chronic diseases poses a huge challenge in primary care. In particular, there is
a deficit regarding monitoring and structured follow-up. Appropriate electronic medical records (EMRs) could help improving
this but, so far, there are no evidence-based specifications concerning the indicators that should be monitored at regular intervals.
Objective: The aim was to identify and collect a set of evidence-based indicators that could be used for monitoring chronic
conditions at regular intervals in primary care using EMRs.
Methods: We searched MEDLINE (Ovid), Embase (Elsevier), the Cochrane Library (Wiley), the reference lists of included
studies and relevant reviews, and the content of clinical guidelines. We included primary studies and guidelines reporting about
indicators that allow for the assessment of care and help monitor the status and process of disease for five chronic conditions,
including type 2 diabetes mellitus, asthma, arterial hypertension, chronic heart failure, and osteoarthritis.
Results: The use of the term “monitoring” in terms of disease management and long-term care for patients with chronic diseases
is not widely used in the literature. Nevertheless, we identified a substantial number of disease-specific indicators that can be
used for routine monitoring of chronic diseases in primary care by means of EMRs.
Conclusions: To our knowledge, this is the first systematic review summarizing the existing scientific evidence on the standardized
long-term monitoring of chronic diseases using EMRs. In a second step, our extensive set of indicators will serve as a generic
template for evaluating their usability by means of an adapted Delphi procedure. In a third step, the indicators will be summarized
into a user-friendly EMR layout.
(JMIR Med Inform 2019;7(2):e10879)   doi:10.2196/10879
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Introduction
In 2016, the World Health Organization estimated that 71% of
the overall deaths worldwide occurred due to noncommunicable
diseases [1]. The majority of these diseases include
cardiovascular diseases, chronic respiratory diseases, and
diabetes. In particular, the prevalence of type 2
(non-insulin-dependent) diabetes mellitus, arterial hypertension,
asthma, chronic heart failure, and musculoskeletal diseases is
increasing rapidly around the world leading to increased
multimorbidity and polypharmacy, especially in the older
population [1,2]. The burden of these diseases consequently
imposes a significant threat to health, quality of life, and
economic status in the affected population. Moreover, the regular
monitoring of chronic diseases poses huge challenges and
requires knowledge and communication skills, as well as the
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capability of organization and coordination. The chronic care
model (CCM) was originally introduced to graphically picture
the concept of disease management [3]. The eHealth enhanced
chronic care model was subsequently introduced as the means
to improve the CCM in view of the progress and development
of information and communication technology [4]. This model
shows the existing variety of technically well-advanced
applications as part of the monitoring process. Too many clinical
offices in Switzerland lack basic electronic devices since many
general practitioners still use paper-based patient records.
In 2012, 31 European countries were ranked based on the usage
of electronic medical records (EMRs) in primary care [5]. In
this global ranking of EMR usage, Switzerland ranked number
24. In a Swiss study, only up to 44.8% of the participating
primary care physicians reported the usage of EMRs [6].
Therefore, it is currently almost impossible to exchange data
with digital applications that are increasingly available and used
by patients [6]. To efficiently monitor patients with chronic
diseases, a well-structured and organized EMR system is crucial
to ensure that all necessary information can be easily entered
and retrieved, while no essential information is missed.
Surprisingly, there are no evidence-based specifications
concerning the indicators that should be monitored at regular
intervals. On one hand, there are currently no international
standards for the monitoring of patients with chronic diseases
by means of EMR in primary care. On the other hand, there are
deficits regarding the actual monitoring and structured
follow-up. Therefore, we aimed to identify and collect a set of
evidence-based indicators that could be used for monitoring
patients with chronic conditions at regular intervals in primary
care using EMRs.
Methods
Systematic Identification and Assessment of
Supporting Evidence
We followed the principles of systematic reviews [7] and
developed a protocol a priori to guide the identification and
assessment of the monitoring indicators.
Inclusion Criteria
We included clinical guidelines and primary peer-reviewed
studies of any design, carried-out mainly in primary care (ie,
family health care) patients aged 18 years and older, who were
diagnosed with type 2 (non-insulin-dependent) diabetes mellitus,
arterial hypertension, asthma, chronic heart failure, or
osteoarthritis. The first four diseases are among the most
common noninfectious diseases worldwide. Osteoarthritis, in
particular, generates a large part of indirect costs [2]. In order
to be included, studies must have also reported on indicators
that allow the assessment of care and help monitor the status
and process of disease for these five chronic conditions.
Therefore, we considered disease indicators that help reduce
the risk of exacerbation, such as intermediate outcome indicators
(eg, hemoglobin A1c [HbA1c] for diabetics or blood pressure
measurements for hypertensive patients) and process indicators
(eg, regular foot care or nutrition counselling). We included
studies regardless of whether specific interventions were
evaluated. In addition, all studies and clinical guidelines should
have been published in English or German.
Search Methods and Study Identification
We developed a comprehensive search strategy in collaboration
with an expert librarian. The librarian conducted the search and
produced a set of studies that matched the predefined search
criteria. We identified studies published between 2000 and 2015
by applying this strategy in MEDLINE (Ovid), Embase
(Elsevier), and the Cochrane Library (Wiley). No restrictions
were made regarding the country of origin of the studies. The
search strategy included a combination of the concepts and
terminology, synonyms and related words for monitoring and
for medical, health, electronic, patient, or file records. It also
included primary, family, health care, or general practitioner,
and the five chronic conditions (ie, type 2
[non-insulin-dependent] diabetes mellitus, arterial hypertension,
asthma, chronic heart failure, and osteoarthritis). The focused
search also included the terminology indicators, parameter, and
management. An example of the full search strategy is available
in Multimedia Appendix 1.
We identified additional publications by manually searching
the reference lists of included studies and relevant reviews. We
also searched for monitoring indicators in the clinical guidelines
in order to identify as many indicators as possible and to enable
a holistic management of chronic diseases. Given that most
guidelines are not indexed in the former medical literature
databases, and to identify the clinical guidelines related to any
of the five chronic diseases, we searched World Wide
Web-based databases, including the National Guideline
Clearinghouse for US guidelines [8] and the
Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen
Fachgesellschaften eV (AWMF) [9] for German guidelines.
Study Selection and Assessment
For study selection, we created a system to prioritize the studies.
One reviewer identified eligible studies by first screening the
titles and abstracts of all records retrieved by the searches based
on the inclusion criteria. All potentially eligible abstracts were
rated manually from one to five stars according to their relevance
for this review. The stars were assigned based on whether or
not the key terms were mentioned (ie, “indicator,” “monitoring,”
“assessment,” “management,” and/or “guideline”). The ranking
was assigned as follows:
1. One star: Remote reference to the key terms; no indicators
expected in full text.
2. Two stars: Little reference to the key terms; indicators in
full text unlikely.
3. Three stars: Reference of at least one key term; indicators
in full text possible.
4. Four stars: Reference of at least one key term; indicators
in full text very possible.
5. Five stars: Reference of indicators, monitoring, or interval
of measuring indicators.
The full text of all studies with an abstract that was rated with
at least two stars was obtained, if available, and further evaluated
based on the reporting of indicators. For studies where the full
text was not available but were deemed important to inform our
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monitoring tool, we used the data reported in the abstract. When
it was necessary, the study team was consulted throughout the
evaluation process to confirm the eligibility of indicators.
Data Extraction and Synthesis
For each included study, we extracted the bibliographic details
(ie, author, year, and country of origin), all the monitoring
indicators reported, the guideline on which the indicators were
based, and the country of origin of the guidelines for each of
the five chronic diseases. One reviewer extracted all data, and
another reviewer verified the extracted data. We compiled a
data profile for each study or guideline, and generated a set of
indicators using Microsoft Excel. We report a descriptive
summary of the indicators for each of the chronic conditions.
Results
Our literature searches identified 795 original records (see Figure
1). After deduplication and perusal of titles and abstracts, we
screened 621 records (range by disease: 33-180) and excluded
408 records that did not meet our inclusion criteria (eg, focused
on specific therapy or medication or did not cover the topic).
We examined in detail the full text, where available, of 213
publications (range by disease: 13 to 82).
Figure 1. Flowchart demonstrating the identification and selection of evidence. a: type 2 diabetes mellitus; b: asthma; c: arterial hypertension; d: heart
failure; e: osteoarthritis; *: 5 of 87 publications (6%) reported indicators for more than one disease of interest.
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We included 87 original publications, 5 (6%) in abstract form
only, reporting indicators for diabetes mellitus [10-63], asthma
[60,64-70], arterial hypertension [10,35,39,71-81], heart failure
[33,82-92], and osteoarthritis [93-96]. Multimedia Appendix 2
presents a list of all included studies that reported monitoring
indicators for the five chronic conditions. A total of 5
publications (6%) reported indicators for more than one chronic
disease [10,33,35,39,60]. The number of included publications
by disease with at least one indicator ranged from 4 to 54. Most
records (54/87, 62%) were published on type 2 diabetes mellitus,
while osteoarthritis was the most underrepresented of the five
diseases, with only 4 records (5%). A total of 74 of all 87
included studies (85%) contained process indicators, the most
significant type of indicators. Concerning diabetes mellitus, a
third of all publications (54/179, 30.2%) reported at least one
indicator. For arterial hypertension and heart failure, only 8%
(7/87) of all publications reported at least one indicator. Overall,
most records used guidelines from the United States, followed
by the United Kingdom. For diabetes mellitus, the American
Diabetes Association and the National Institute for Health and
Care Excellence were the most-used guidelines. The most
frequently mentioned indicators for diabetes are presented in
Table 1. The indicators for the other four diseases are presented
in Multimedia Appendices 3-6.
Table 1. Diabetes mellitus indicators that are most frequently mentioned in guidelines and studies. The indicators are sorted first by guidelines and
then by studies.
Number of studies where indicators are mentionedNumber of guidelines where indicators
are mentioned (guidelines)
Indicators for diabetes mellitus
20 [10,12,13,18,21,23,25,30-32,41,43-46,50-52,60,61]7 (a-g)aFundoscopic examination
33 [11-16,18,20,21,23-25,27-29,32,33,35,40,41,44,45,48,
49,53-56,58-60,62,63]
7 (a-g)Height, weight, and body mass index
45 [11,13,15-27,29-36,39-45,47-49,52,53,55,56,58-63]7 (a-g)Blood pressure measurement
N/Ab7 (a-g)10 g monofilament
46 [10,12,13,15-23,26,28-37,39-45,47-54,56-63]7 (a-g)Hemoglobin A1c (ie, glycated hemoglobin)
17 [12,15,18,21,23,25,30-32,43-46,50-52,61]7 (a-g)Foot inspection
N/A7 (a-g)Erectile dysfunction
18 [12,13,18,22,23,25,31,32,35,41,43-46,51,55,61,62]7 (a-g)Albuminuria
8 [25,26,30,43,45,46,52,61]7 (a-g)Lipid profile
30 [11,12,15,18-20,22-24,29,31-37,41-44,47-49,52-54,63]N/ALow-density lipoprotein
14 [11,20,23,28,29,33,37,39,49,51,53,54,62,63]N/AHigh-density lipoprotein
15 [20,29,30,33,37,39,48,49,51,53-55,57,62,63]N/ATriglyceride
18 [13,15,16,22,25-27,29,33,41,46,51,55,57-60,62]7 (a-g)Creatinine
2 [24,53]7 (a-g)Alcohol intake
3 [18,20,55]7 (a-g)Neuropathy and history of foot lesion
2 [18,22]6 (a-f)History of myocardial infarction (ie, cardiovas-
cular disease)
3 [18,32,60]6 (a-f)Foot pulses
24 [11-15,18,20,22-24,26,28,29,31,35,41,44,48,50,53,
58-61]
6 (a-f)Smoking status
N/A5 (a, b, d, e, g)Orthostatic hypotension
N/A5 (a, b, d, f, g)Skin inspection
1 [60]5 (a-d, g)Vibration by 128 Hz tuning fork
12 [11,21,24,33,39,45,51,54,55,57,59,63]4 (b-d, g)Plasma glucosis
9 [11,18,22,23,28,48,55,58,59]3 (b, c, f)Onset of diabetes
N/A225Indicators appeared in fewer than five guide-
lines
76N/AIndicators appeared in fewer than 10 studies
aThe letters a-g refer to the guidelines listed in Multimedia Appendices 7-11.
bN/A: not applicable.
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In total, there were 249 indicators for type 2 diabetes mellitus,
183 for asthma, 335 for arterial hypertension, 231 for chronic
heart failure, and 164 for osteoarthritis. The majority of
indicators were identified by screening both peer-reviewed
articles and clinical guidelines. A few extra indicators were
reported only in peer-reviewed articles. That is, clinical
guidelines on their own contributed to the great majority of all
indicators identified. Surprisingly, only a few guidelines, such
as the American guideline for asthma, included a section
dedicated to monitoring or follow-up. Most of the guidelines
that we screened did not specify the interval at which the
indicators should be monitored. Also, in some guidelines,
self-monitoring was a big topic for chronic heart disease (ie,
weight control), asthma (ie, peak expiratory flow), and type 2
diabetes mellitus (ie, glucose monitoring).
Our systematic review also found that the term “monitoring,”
in the sense of long-term patient care, was not widely used.
Although publications reported the actual monitoring indicators,
the process of monitoring for the different diseases, including,
for example, the potential risks associated with overmonitoring,
was only scarcely addressed. The publication by Glasziou was
the only one giving a broader overview on the topic [97]. Only
a handful of publications reported a complete set of indicators
that can be used for monitoring, but these were either not
specific for primary care or not eligible for implementation in
EMRs [98-101].
Discussion
Principal Findings
To our knowledge, this study represents the first summary of
the existing scientific evidence about the indicators that help
standardize the monitoring of chronically ill patients in primary
care by the use of EMRs. Long-term care of patients with
chronic diseases is challenging and there are deficits regarding
their monitoring and structured follow-up. Chronic care often
involves collaboration between several people involved in the
treatment process. That is only one reason for its complexity.
Interpersonal differences in monitoring can decrease the quality
of monitoring processes. Surprisingly, there are currently no
gold standards or consensus regarding the systematic monitoring
of patients with chronic diseases, in particular by means of
EMRs. To efficiently monitor patients with chronic diseases, a
well-structured and organized EMR system is crucial to ensure
that all necessary information can be easily entered and retrieved
and that no essential information is missed. Our study is, thus,
the first initiative toward the urgent need of standardization for
monitoring patients with chronic diseases in primary care.
Our systematic literature review showed that the term
“monitoring” in terms of disease management and long-term
patient care is not widely used. There is a plethora of literature
about quality indicators that might have the potential to improve
the outcome of a disease. The Quality and Outcomes Framework
(QOF) in the United Kingdom, for example, assesses indicators
for such purposes [102]. Beyond identifying indicators that can
be easily assessed, such as the indicators used by the QOF, our
goal was to summarize the existing literature on all the indicators
available for long-term monitoring.
So far, only a few authors have focused on the topic of the
monitoring of chronic diseases. According to Glasziou, the
process of monitoring aims to establish the response to treatment
and to detect both adverse effects and the need to adjust
treatment [97]. The process of monitoring can be divided into
different phases (ie, pretreatment, during treatment, and after
treatment). Each phase requires measurements at different
intervals.
When analyzing different diseases, monitoring is probably most
widely mentioned in blood pressure management. There are
various publications reporting on the optimal way and interval
of measuring blood pressure [76,103,104]. However, literature
beyond the indicator of blood pressure measurement remains
scarce. Regarding diabetes mellitus, there is an extended
monitoring tool that was designed as a disease management tool
for practice nurses [101]. The tool’s design is based on a traffic
light scheme to detect any deficit and need for action. In
addition, a detailed guideline on how to monitor the diabetic
foot is provided by the International Working Group on the
Diabetic Foot [105]. As for bronchial asthma, two study groups
have addressed the optimal way and potential problems of
finding and evaluating indicators to monitor patients with
asthma, including an overview of the most important indicators
[98,100]. Similarly, Grypdonck presents a small set of indicators
for monitoring patients with osteoarthritis of the knee [93].
Self-monitoring seems to be an important topic concerning
osteoarthritis and asthma. An English study conducted by
interviewing general practitioners about osteoarthritis showed
that the majority of respondents thought monitoring of
osteoarthritis is important, even though almost half did not
monitor patients at all. Interestingly, more than half of the
respondents felt that patients should do self-monitoring [106].
Patient involvement is crucial for monitoring. Particularly, in
high-frequency monitoring situations such as chronic heart
failure, telecardiological service, including transtelephonic
monitoring, reduces the length of hospitalization and improves
quality of life [91]. Surprisingly, publications concerning
monitoring of chronic heart failure seem to be scarce [90]. The
underrepresentation of osteoarthritis and chronic heart failure
is also reflected in the number of indicators detected in the
primary literature, compared to a large number of records
reporting on indicators for type 2 diabetes mellitus. Another
topic repeatedly found in the results was the involvement of a
clinical practice nurse in monitoring [101,107-109]. The clinical
nurse can, for example, fill out a monitoring questionnaire in
face-to-face sessions with the patient, on the phone, or even
electronically. This could counteract the problem of workload
and time constraints as a frequent response to why monitoring
is not conducted [106].
Strengths and Limitations
To our knowledge, this study represents the first scientifically
founded recommendation for the standardized long-term
monitoring of chronically ill patients in primary care. Usually,
systematic reviews only concentrate on primary literature and
do not include guidelines in their search strategy, since most
guidelines are not indexed in databases. In our study, we
explicitly searched for guideline programs such as the National
Guideline Clearinghouse for American guidelines and the
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AWMF for German guidelines. We added a substantial number
of manual searches within reference lists and search engines in
order to gain a maximal insight of the existing literature. This
strategy was worth the extra effort, considering that most
relevant indicators were found in guidelines and not in the
primary literature. Possible confounders are that publications
and guidelines reported in languages other than German and
English were excluded.
Outlook
In a second step, our extensive set of indicators obtained from
this work will serve as a generic template for a monitoring tool.
By means of an adapted Delphi procedure, the indicators will
be further evaluated in terms of their usability. In a third step,
the indicators will be summarized into a user-friendly EMR
layout.
Conclusion
This is the first study that systematically summarizes the existing
scientific evidence about the standardized long-term monitoring
of chronic diseases by means of EMRs. It aims to help improve
care for patients with chronic diseases in primary care.
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Appendix 1 
Search strategy for (OVID) MEDLINE*.  
# Searches Results 
1 (exp Medical Records/ or ((medical or patient) adj3 (record* or file)).ab,ti.) 
and (general practitioners/ or physicians, family/ or exp Primary Health Care/ 
or ((general or family or primary) adj3 (doctor* or physician* or 
practi*)).ab,ti.) and (exp Automatic Data Processing/ or indicator.ab,ti. or 
managment.ab,ti. or monitoring.ab,ti. or parameter.ab,ti. or ((clinical or 
laboratory) adj3 (data or assess* or finding* or observ* or monitor* or 
examin* or check* or control*)).ab,ti. or ((data or information) adj6 (set or 
extract* or analys* or retriev* or yield* or gather*)).ab,ti. or (data adj6 
(standard* or normali* or form*)).ab,ti. or ("data from" adj6 (file or 
record)).ab,ti.) 
2088 
2 limit 1 to (yr="2000 -Current" and (english or german)) 1593 
3 exp Diabetes Mellitus, Type 2/ 91561 
4 2 and 3 74 
5 (self monitoring or (monitoring adj3 glucose)).ab,ti. 9074 
6 4 not 5 69 
7 exp Hypertension/ 215840 
8 2 and 7 79 
9 exp Heart Failure/ 91040 
10 2 and 9 22 
11 exp heart failure/ or exp myocardial ischemia/ 442513 
12 2 and 11 60 
13 12 not 10 38 
14 exp Asthma/ 108981 
15 2 and 14 37 
16 exp Arthritis/ 209132 
17 2 and 16 16 
*Similar search strategies were applied in Embase and Cochrane. 
 
Appendix 2 
List of all included studies including monitoring indicators for the five chronic conditions. 
First author Year of 
publication 
Country of origin Guideline used in the 
publication 
Country of 
origin of 
guideline 
Referenc
e number 
Diabetes mellitus 
Suija 2015 Estonia Organisation for Economic 
Co-operation and 
Development (OECD), 
American Diabetes 
Association (ADA), World 
Health Organization WHO, 
European Society of 
Cardiology (ESC), National 
Institute for Health and 
Care Excellence (NICE) 
various [10] 
Shah 2015 United Kingdom unknown   [11] 
Devkota 2015 USA American Diabetes 
Association (ADA) 
USA [12] 
Barkhuysen 2014 Netherlands Dutch College of General 
Practitioners 
Netherlands [13] 
Szczech 2014 USA Kidney Disease Outcomes 
Quality Initiative (KDOQI) 
USA [14] 
van Melle 2014 Netherlands Dutch College of General 
Practitioners 
Netherlands [15] 
Djalali 2014 Switzerland Quality and Outcomes 
Framework indicator 
(QOF) 
United 
Kingdom 
[16] 
Goff 2014 USA unknown   [17] 
Vidal-Pardo 2013 Spain "Plan de Saude" (Health 
plan of Galicia) 
Spain [18] 
Sidorenkov 2013 Netherlands Quality and Outcomes 
Framework indicator 
(QOF), Dutch College of 
General Practitioners 
United 
Kingdom, 
Netherlands 
[19] 
Winkley 2013 United Kingdom unknown   [20] 
Gavran 2012 Bosnia/Herzegovin
a 
The Committee for 
Practice Guidelines (CPG)  
Europe [21] 
Knudsen 2012 Denmark Danish National guidelines Denmark [22] 
Mata-Cases 2012 Spain RedGDPS (Spain) Spain [23] 
Nouwens 2012 Netherlands Dutch College of Family 
Physicians 
Netherlands [24] 
Satman 2012 Turkey Standard Diabetes 
Management Procedures 
of Turkey 
Turkey [25] 
Marley 2012 Australia unknown   [26] 
Patapas 2012 Canada unknown   [27] 
Staff 2012 Asutralia United Kingdom 
Prospective Diabetes 
Study 
United 
Kingdom 
[28] 
Hill 2012 Ireland indicators selected by 
authors 
 [29] 
Alfadda 2011 Saudi Arabia American Diabetes 
Association (ADA) 
USA [30] 
Dickerson 2011 USA Diabetes Recognition 
Program (DRP) by the 
National Committee for 
Quality Assurance (NCQA) 
USA [31] 
Vidal Pardo 2011 Spain "Plan de Saude" (Health 
plan of Galicia) 
Spain [32] 
Weenink 2011 Netherlands unknown   [33] 
Gladstone 2011 USA Canadian Practice 
Guidelines 
Canada [34] 
Holbrook 2011 Canada unspecific cardiovascular 
risk factors 
  [35] 
O'Connor 2011 USA unknown   [36] 
Sundquist 2011 SWE Swedish National 
Guidelines 
Sweden [37] 
Reddy 2010 Australia Quality and Outcomes 
Framework indicator 
(QOF) 
United 
Kingdom 
[38] 
Samoutis 2010 Cyprus American Diabetes 
Association (ADA), St. 
Vincent Declaration 
USA, Europe [39] 
Shah 2010 Canada Canadian Diabetes 
Association 
Canada [40] 
Petrazzuoli 2010 Italy Quality and Outcomes 
Framework indicator 
(QOF) 
United 
Kingdom 
[41] 
Sperl-Hillen 2010 USA American Diabetes 
Association (ADA) 
USA [42] 
Pedersen 2009 Greenland Danish National Indicator 
Project 
Denmark [43] 
Holbrook 2009 Canada Canadian Diabetes 
Association and American 
Diabetes Association 
(ADA) 
Canada, USA [44] 
Moharram 2008 Saudi Arabia Canadian Diabetes 
Association 
Canada [45] 
Novo 2008 Bosnia/Herzegovin
a 
Canadian Diabetes 
Association 
Canada [46] 
Samuels 2008 USA American Diabetes 
Association (ADA) 
USA [47] 
Smith 2008 USA American Diabetes 
Association (ADA), 
National Committee for 
quality assurance 
USA [48] 
Voorham 2008 NL National Guidelines of 
Netherlands 
Netherlands [49] 
Wens 2007 Belgium various guidelines Belgium, 
Netherlands
, Germany, 
United 
Kingdom, 
France 
[50] 
Nitiyanant 2007 Thailand unknown   [51] 
Herrin 2006 USA National Diabetes Quality 
Improvement Alliance 
guidelines 
USA [52] 
Wan 2006 Australia Australian guidelines for 
diabetes management in 
general practice, National 
Australia, 
United 
Kingdom 
[53] 
Institute for Health and 
Care Excellence (NICE) 
Al Khaja 2005 Bahrain The Seventh Report of the 
Joint National Committee 
(JNC-7) 
USA [54] 
Cueto-
Manzano 
2005 Mexico unknown   [55] 
Lusignan 2005 United Kingdom National Institute for 
Health and Care Excellence 
(NICE) 
United 
Kingdom 
[56] 
Sequeira 2004 Bahrain The Sixth Report of the 
Joint National Committee 
(JNC-6)/International 
Society of Hypertension 
(ISH) 
USA, 
internationa
l 
[57] 
Wermeille 2004 Switzerland unknown   [58] 
Goudswaard 2003 Netherlands Dutch College of General 
Practitioners 
Netherlands [59] 
Campbell 2002 United Kingdom Developed within study   [60] 
Parchman 2002 USA American Diabetes 
Association (ADA) 
USA [61] 
Renders 2001 Netherlands Dutch College of General 
Practitioners 
Denmark [62] 
Linmans 2001 Netherlands unknown   [63] 
Asthma 
Minard 2014 Canada Asthma Care Map Canada [64] 
Lim 2012 USA National Assessment of 
Educational Progress 
(NAEP) 
USA [65] 
Lougheed 2012 Canada Canadian Asthma 
Consensus 
Guidelines/Canadian 
Thoracic Society  
Canada [66] 
Oei 2011 Australia unknown 
 
[67] 
Nokela 2010 Sweden unknown 
 
[68] 
Yawn 2008 USA APGAR tool/ National 
Heart, Lung, and Blood 
Institute (NHLBI) 
USA [69] 
Baddar 2006 Oman Oman’s national Manual 
for the Management of 
Asthma in Adults 
Oman [70] 
Campbell 2002 United Kingdom indicators selected by 
authors 
 
[60] 
Arterial hypertension 
Suija 2015 Estonia Organisation for Economic 
Co-operation and 
Development (OECD), 
European Society of 
Cardiology (ESC), World 
Health Organization 
(WHO)/ International 
Society of Hypertension 
(ISH) 
internationa
l, Europe 
[10] 
Hasselstrom 2014 Sweden unknown  [71] 
Tong 2012 Malaysia Clinical Practice Guideline 
for Hypertension in 
Malaysia 
Malaysia [72] 
Holbrook 2011 Canada unknown  [35] 
Samoutis 2010 Cyprus Report of the Joint 
National Committee (JNC), 
the European guidelines 
on cardiovascular disease 
prevention and the 
European Society of 
Hypertension, European 
Society of Cardiology 
Guidelines. 
USA, Europe [39] 
Pavlik 2009 USA The Seventh Report of the 
Joint National Committee 
(JNC-7) 
USA [73] 
Chan 2006 China Eli Lilly National clinic audit 
center, Report of the Joint 
National Committee (JNC) 
United 
Kingdom, 
USA 
[74] 
Asnani 2005 Jamaica Ministry of Health Jamaica [75] 
Rabinowitz 2005 Israel American Heart 
Association 
USA [76] 
(AHA)/American College of 
Cardiology (ACC), National 
Cholesterol Education 
Program 
Mitchell 2005 United Kingdom unknown  [77] 
Alli 2005 Italy unknown  [78] 
Tierney 2004 USA unknown  [79] 
Lackland 2004 USA The Seventh Report of the 
Joint National Committee 
(JNC-7) 
USA [80] 
Frijling 2003 Netherlands Dutch college of General 
Practitioners 
Netherlands [81] 
Heart failure 
Amarasingha
m 
2013 USA unknown  [82] 
Logeart 2013 France European Society of 
Cardiology (ESC) 
Europe [83] 
Weenink 2011 Netherlands unknown  [33] 
Lind 2011 Sweden unknown  [84] 
Korb 2010 Germany Deutsche Gesellschaft für 
Allgemeinmedizin und 
Familienmedizin (DEGAM)-
Leitlinie 
Germany [86] 
Maddocks 2010 Canada Heart failure management 
incentive (ministry of 
health and long-term care) 
Canada [85] 
Fonarow 2010 USA American College of 
Cardiology/American 
Heart Association 
USA [87] 
Vercauteren 2009 Belgium unknown  [88] 
Majeed 2005 United kingdom Quality and Outcomes 
Framework indicator 
(QOF) 
United 
Kingdom 
[89] 
Roth 2004 Israel unknown  [91] 
Subramanian 2004 USA Kansas City 
Cardiomyopathy 
Questionnaire 
USA [90] 
Gnani 2004 United Kingdom Quality and Outcomes 
Framework indicator 
(QOF) 
United 
Kingdom 
[92] 
Osteoarthritis 
Grypdonck 2014 Belgium indicators selected by 
authors 
 [93] 
Jansen 2010 Netherlands Osteoarthritis of the hip 
and knee for physical 
therapist 
Netherlands [94] 
MacLean 2004 USA indicators selected by 
authors 
 [95] 
Peat 2002 United Kingdom indicators selected by 
authors 
 [96] 
 
Appendix 3 
Asthma indicators mentioned in guidelines and studies. The indicators are sorted first by guidelines 
and then by studies. 
indicators for asthma appeared in guidelines appeared in studies 
Fev1/FVC Ratio 6 (a-f) - 
lung function 6 (a-f) 3 [64, 66, 69] 
Daytime asthma symptoms 6 (a-f)  4 [60, 64, 66, 69] 
Any night waking due to asthma 5 (a, c-f) 5 [60, 64, 66, 68, 69] 
Any activity limitation due to asthma 5 (a, c-f) 4 [60, 64, 66, 69] 
FEV1 5 (a-c, e, f) 1 [68] 
PEF (self-monitoring) 5 (a-c, e, f 4 [60, 64, 68, 70] 
wheezing 4 (b-e) 2 [64, 69] 
cough 4 (b-e) 2 [64, 69] 
Reliever needed for symptoms more 
than twice per week 
4 (a, c, d, f) 2 [64, 68] 
smoking habit 4 (a-d) 3 [60, 65, 68] 
auscultation 4 (a, b, d, e) - 
bronchial provocation test 4 (a, b, d, e) - 
variation in lung function 4 (a, d-f) - 
check inhaler technique 3 (a-c) 4 [60, 64, 69, 70] 
trigger of symptoms 3 (a, c, d) 3 [64, 69, 70] 
hospital stays or emergency department 
visits since last visit 
1 (c) 3 [64, 66, 70] 
medication history 2 (a,c) 3 [64, 69, 70] 
smoking cessation advice - 3 [60, 64, 66] 
check adherence 2 (a,c) 3 [64, 68, 70] 
asthma action plan - 3 [64, 66, 69] 
indicators appeared in less than 4 
guidelines 
162  
indicators appeared in less than 3 
studies 
 38 
 
Letters a-f refers to the guidelines listed in Appendix 8; FEV1/FVC Ratio: Tiffeneau-Pinelli index. 
FEV1: Forced expiratory volume at one second. PEF: peak expiratory flow. 
Appendix 4 
Arterial hypertension indicators mentioned in guidelines and studies. The indicators are sorted first by 
guidelines and then by studies.  
indicators for arterial hypertension appeared in guidelines appeared in studies 
smoking habit 8 (a-h) 11 [35, 71-79, 81] 
blood pressure 8 (a-h) 9 [10, 35, 39, 71-73, 75, 77-
79] 
choose correct cuff 8 (a-h) 1 [75] 
standing blood pressure 8 (a-h) - 
electrocardiogramm 8 (a-h) 2 [72, 75] 
fasting blood glucose and or HbA1c 8 (a-h) 6 [39, 71, 72, 75, 79, 80] 
serum totalcholesterine 8 (a-h) 8 [10, 39, 71, 72, 74, 75, 79, 
80] 
high density lipoprotein 8 (a-h) 5 [39, 71, 72, 76, 80] 
creatinine 8 (a-h) 4 [71, 75, 79, 80] 
potassium 8 (a-h) 3 [75, 79, 80] 
age 7 (a-f, h) 2 [76, 78] 
history of chronic kidney disease 7 (a, c-h) 2 [78, 79] 
recreational drug use 7 (a, c-h) - 
current medication 7 (a, c-h) 3 [73, 75-77] 
family history 7 (a-d, g, h) 3 [72, 74, 76] 
family history for coronary heart disease 7 (a-d, g, h) 3 [72, 74, 76] 
BMI/weight 7 (a-f, h) 8 [35, 71, 72, 74-76, 78, 79] 
resting comfortably for several minutes 
prior to blood pressure measurement 
7 (a, b, d-h) - 
measure blood pressure on both arms 7 (a-e, g,h) - 
Home blood pressure monitoring or 
ambulatory blood pressure monitoring if 
suspected white coat hypertension 
7 (a-g) - 
eye examination 7 (a-d, e-h) 3 [72, 74, 75] 
echocardiography if needed 7 (a-c, e-h) - 
low density lipoprotein 7 (a, b, d-h) 6 [35, 39, 71, 72, 76, 80] 
triglycerides 7 (a, b, d-h) 6 [39, 71, 72, 75, 76, 80] 
Assessment of microalbuminuria 7 (a, b, d-h) 4 [71, 72, 79, 80] 
sedentary lifestyle 6 (a, d-h) 5 [35, 74-76, 78] 
diabetes mellitus in history 6 (a, c, d, f-h) 6 [72, 74, 76-79] 
alcohol 3 (e, g, h) 4 [74, 75, 78, 79] 
history of coronary heart 
disease/cardiovascular disease/stroke 
5 (a, d-g) 2 [77-79] 
indicators appeared in less than 7 guidelines 307  
indicators appeared in less than 3 studies  58 
 
Letters a-h refer to the guidelines listed in Appendix 9; BMI: body mass index. 
 
Appendix 5 
Chronic heart failure indicators most frequently mentioned in guidelines and studies. The indicators 
are sorted first by guidelines and then by studies.  
indicators for chronic heart 
failure 
appeared in guidelines appeared in studies 
sodium 6 (a-f) 4 [33, 85, 87, 89] 
potassium 6 (a-f) 3 [33, 85, 89] 
creatinine 6 (a-f) 5 [33, 82, 83, 85, 87] 
daily weight measurement 5 (a, b, d-f) 3 [84, 88, 91] 
changes in weight 5 (a, b, d-f)  
depression 5 (a, c-f) - 
address palliative or hospice care 5 (a, c, d-e) - 
NYHA-classification 5 (a, c-f) 2 [87, 90] 
pulse rate 5 (a-c, e-f) 3 [83, 85, 87] 
exercise capacity 5 (a, b, d-f) 2 [86, 90] 
erectile dysfuntion/sexual activity 4 (a, d, e, f) - 
measure blood pressure 4 (a, b, d, e) 5 [33, 85, 87, 89, 92] 
measure daily blood pressure  3 [84, 88, 91] 
electrocardiography 4 (a, d-f) 4 [85, 86, 89, 92] 
echocardiogram with doppler 4 (a, d-f) 6 [85-89, 92] 
NT-proBNP 3 (d-f) 5 [82, 83, 86-88] 
chest radiography if necessary 3 (d-f) 4 [85, 86, 89, 92] 
BMI 2 (e, f) 3 [33, 85, 89] 
history/signs of diabetes mellitus 3 (a, d, f) 3 [82, 87, 89] 
number of indicators that appeared in 
less than 4 guidelines 
213  
number of indicators that appeared in 
less than 3 studies 
 47 
 
Letters a-f refer to the guidelines listed in Appendix 10; NT-proBNP: N-terminal prohormone Brain 
natriuretic peptide. BMI: body mass index. 
Appendix 6 
 
Osteoarthritis indicators most frequently mentioned in guidelines and studies. The indicators are 
sorted first by guidelines and then by studies.  
indicators for osteoarthritis appeared in guidelines appeared in studies 
tenderness 4 (a-d)  
significant loss of range of movement 4 (a-d)  
assessment of functional status  2 [94, 95] 
mood 3 (a-c)  
health believes 3 (a-c)  
expectations, concerns, ideas 3 (a-c)  
stiffness 3 (a, c, d)  
stress pain 3 (a, c, d)  
activity of daily living 3 (a, b, d)  
Hobbies 3 (a-c)  
history of trauma 3 (a, c, d)  
swelling 3 (a, c, d)  
redness 3 (a-c)  
deformity 3 (a, b, d)  
advise on losing and maintaining weight  2 [93, 95] 
assessment of pain  2 [94, 95] 
number of indicators that appeared in 
less than 3 guidelines 
148  
number of indicators that appeared in 
only one study 
 38 
 
Letters a-f refer to the guidelines listed in Appendix 11. 
 
Appendix 7 
 
Guidelines screened for indicators for diabetes mellitus type2. 
 
Diabetes mellitus Year (last update) editor/publisher country  
Standards of Medical 
Care in Diabetes 
2014 American Diabetes Association 
(ADA) 
USA a 
Nationale 
VersorgungsLeitlinien 
2013, 2015 Bundesärztekammer (BÄK), 
Kassenärztliche 
Bundesvereinigung (KBV), 
Arbeitsgemeinschaft der 
Wissenschaftlichen 
Medizinischen 
Fachgesellschaften (AWMF) 
(AWMF Institute for Medical 
Knowledge Management) 
Germany b 
National Institute for 
Health and Care 
Excellence (NICE) 
2014 Royal College of Physicians England c 
Global Guideline for Type 
2 Diabetes 
2012 International Diabetes 
Federation 
International d 
General practice 
management of type 2 
diabetes 
2014 The Royal Australian College of 
General Practitioners 
Australa e 
Clinical Practice 
Guidelines 
2013 Canadian Diabetes Association Canada f 
MediX-Guideline zu 
Diabetes mellitus 
2013 MediX Schweiz g 
 
Appendix 8 
Guidelines screened for indicators for asthma. 
Asthma Year (last update) editor/publisher country 
 
Global strategy for 
Asthma Management 
and Prevention 
2015 Global Initiative for Asthma 
(GINA) 
international a 
Asthma: diagnosis and 
monitoring of asthma 
in adults, children and 
young people 
Draft for 
Consultation 
2015 
National Institute for Health 
and Care Excellence (NICE) 
England b 
Guidelines for the 
Diagnosis and 
Management of 
Asthma 
2007 National Heart, Lung, 
and Blood Institute (NHBLI) 
USA c 
Australian Asthma 
Handbook  
(Quick Reference 
Guide) 
2014 The Royal Australian College of 
General Practitioners 
Australia d 
Leitlinien zu 
Diagnostik und 
Therapie von 
Patienten mit Asthma 
2006 Deutsche Atemwegsliga, 
Deutsche Gesellschaft für 
Pneumologie und 
Beatmungsmedizin e.V. 
Germany e 
MediX-Guideline zu 
Asthma bronchiale 
2011 MediX Switzerland f 
 
Appendix 9 
Guidelines screened for indicators for arterial hypertension. 
Arterial 
hypertension 
Year (last 
update) editor/publisher country 
 
Leitlinien für das 
Management der 
arteriellen Hypertonie 
(Guidelines for 
management of 
arterial hypertension) 
2013 Deutsche Gesellschaft für 
Kardiologie-, Herz- und 
Kreislaufforschung (DGK) 
(German Cardiac Society) and 
Deutsche Hochdruckliga e.V. 
DHL® Deutsche Gesellschaft 
für Hypertonie und 
Prävention 
Germany a 
Practice Guidelines 
for the Management 
of Arterial 
Hypertension 
2007 The European Society of 
Cardiology (ESC) and 
European Society of 
Hypertension (ESH) 
Europe b 
Clinical management 
of primary 
hypertension in adults 
2013 National Institute for Health 
and Clinical Excellence (NICE) 
England c 
The Seventh Report of 
the Joint National 
Committee on 
Prevention, 
Detection, Evaluation, 
and Treatment of 
High Blood Pressure 
2003 National Heart, Lung, and 
Blood Institute (NHLBI) 
USA d 
The 2015 Canadian 
Hypertension 
Education Program 
Recommendations 
2015 Hypertension Canada Canada e 
Clinical Practice 
Guidelines for the 
Management of 
Hypertension in the 
Community 
2014 The American Society of 
Hypertension and the 
International Society of 
Hypertension (ISH) 
USA, 
international 
f 
Guide to 
management of 
hypertension 2008 
(Assessing and 
managing raised 
blood pressure in 
adults) 
2010 National Heart Foundation of 
Australia 
Australia g 
Arterielle Hypertonie 
Empfehlungen für 
Ärzte  
 
2015 Swiss Society of Hypertension 
(Schweizerische Hypertonie 
Gesellschaft) 
Switzerland h 
 
Appendix 10 
Guidelines screened for indicators for chronic heart failure. 
Chronic heart 
failure 
Year (last 
update) editor/publisher country 
 
Nationale 
VersorgungsLeitlinie 
2011 Bundesärztekammer (BÄK), 
Kassenärztliche 
Bundesvereinigung (KBV), 
Arbeitsgemeinschaft der 
Wissenschaftlichen 
Medizinischen 
Fachgesellschaften (AWMF) 
(AWMF Institute for Medical 
Knowledge Management) 
Germany a 
Anforderungen an ein 
Modul „Chronische 
Herzinsuffizienz“ für 
strukturierte 
Behandlungsprogramme 
für Koronare 
Herzkrankheit (KHK) 
-- Empfehlungen des 
Gemeinsamen 
Bundesausschusses gemäss 
§137f Abs. 2 SGB V für die 
Rechtsverordnung nach § 266 
Abs. 7 SGB V 
Germany b 
Chronic Heart Failure; 
National clinical 
guideline for diagnosis 
and management in 
primary and secondary 
care 
2010 National Institute for Health 
and Clinical Excellence (NICE) 
England c 
ESC Guidelines for the 
diagnosis and treatment 
of acute and chronic 
heart failure 2012 
2012 The European Society of 
Cardiology (ESC) 
Europe d 
Guideline for the 
Management of Heart 
Failure 
2013 The American College of 
Cardiology Foundation and 
the American Heart 
Association 
USA e 
Guidelines for the 
prevention, detection 
and management of 
chronic heart failure in 
Australia 
2011 National Heart Foundation of 
Australia 
Australia f 
 
Appendix 11 
Guidelines screened for indicators for osteoarthritis. 
Osteoarthritis Year (last update) editor/publisher country 
 
Osteoarthritis; Care 
and management in 
adults 
2014 National Institute for Health 
and Clinical Excellence (NICE) 
England a 
EULAR 
recommendations for 
the non-
pharmacological core 
management of hip 
and knee 
osteoarthritis 
2013 The European League against 
Rheumatism 
Europe b 
Guideline for the non-
surgical management 
of hip and knee 
osteoarthritis 
2009  The Royal Australian College 
of General Practitioners 
Australia c 
MediX-Guideline zu 
Arthrose 
2013 MediX Schweiz d 
 
